These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11505331)

  • 1. [A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study].
    Madisch A; Melderis H; Mayr G; Sassin I; Hotz J
    Z Gastroenterol; 2001 Jul; 39(7):511-7. PubMed ID: 11505331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial.
    Madisch A; Holtmann G; Mayr G; Vinson B; Hotz J
    Digestion; 2004; 69(1):45-52. PubMed ID: 14755152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.
    Rösch W; Vinson B; Sassin I
    Z Gastroenterol; 2002 Jun; 40(6):401-8. PubMed ID: 12055663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast).
    Melzer J; Rösch W; Reichling J; Brignoli R; Saller R
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1279-87. PubMed ID: 15606389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study.
    von Arnim U; Peitz U; Vinson B; Gundermann KJ; Malfertheiner P
    Am J Gastroenterol; 2007 Jun; 102(6):1268-75. PubMed ID: 17531013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
    Rösch W; Liebregts T; Gundermann KJ; Vinson B; Holtmann G
    Phytomedicine; 2006; 13 Suppl 5():114-21. PubMed ID: 16978851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of the efficacy and safety of the phytopharmacon STW 5 versus metoclopramide in functional dyspepsia--a retrolective cohort study].
    Raedsch R; Hanisch J; Bock P; Sibaev A; Vinson B; Gundermann KJ
    Z Gastroenterol; 2007 Oct; 45(10):1041-8. PubMed ID: 17924300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms involved in the gastro-protective effect of STW 5 (Iberogast) and its components against ulcers and rebound acidity.
    Khayyal MT; Seif-El-Nasr M; El-Ghazaly MA; Okpanyi SN; Kelber O; Weiser D
    Phytomedicine; 2006; 13 Suppl 5():56-66. PubMed ID: 16963243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STW 5 (Iberogast) and its individual herbal components modulate intestinal electrophysiology of mice.
    Sibaev A; Yuece B; Kelber O; Weiser D; Schirra J; Göke B; Allescher HD; Storr M
    Phytomedicine; 2006; 13 Suppl 5():80-9. PubMed ID: 16713219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy of a combination herbal medicine in the treatment of functional dyspepsia. Meta-analysis of randomized double-blind studies on the basis of a valid gastrointestinal symptom profile].
    Gundermann KJ; Godehardt E; Ulbrich M
    MMW Fortschr Med; 2004 Aug; 146 Suppl 2():71-6. PubMed ID: 16739362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum.
    Schemann M; Michel K; Zeller F; Hohenester B; Rühl A
    Phytomedicine; 2006; 13 Suppl 5():90-9. PubMed ID: 16765572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracts from peppermint leaves, lemon balm leaves and in particular angelica roots mimic the pro-secretory action of the herbal preparation STW 5 in the human intestine.
    Allam S; Krueger D; Demir IE; Ceyhan G; Zeller F; Schemann M
    Phytomedicine; 2015 Nov; 22(12):1063-70. PubMed ID: 26547528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis.
    Braden B; Caspary W; Börner N; Vinson B; Schneider AR
    Neurogastroenterol Motil; 2009 Jun; 21(6):632-8, e25. PubMed ID: 19220753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of functional constipation with the Yun-chang capsule: a double-blind, randomized, placebo-controlled, dose-escalation trial.
    Jia G; Meng MB; Huang ZW; Qing X; Lei W; Yang XN; Liu SS; Diao JC; Hu SY; Lin BH; Zhang RM
    J Gastroenterol Hepatol; 2010 Mar; 25(3):487-93. PubMed ID: 20370727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study.
    Madisch A; Heydenreich CJ; Wieland V; Hufnagel R; Hotz J
    Arzneimittelforschung; 1999 Nov; 49(11):925-32. PubMed ID: 10604046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia.
    May B; Kuntz HD; Kieser M; Köhler S
    Arzneimittelforschung; 1996 Dec; 46(12):1149-53. PubMed ID: 9006790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial.
    Madisch A; Holtmann G; Plein K; Hotz J
    Aliment Pharmacol Ther; 2004 Feb; 19(3):271-9. PubMed ID: 14984373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of STW 5 (Iberogast) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors.
    Simmen U; Kelber O; Okpanyi SN; Jaeggi R; Bueter B; Weiser D
    Phytomedicine; 2006; 13 Suppl 5():51-5. PubMed ID: 16973340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine.
    Müller MH; Liu CY; Glatzle J; Weiser D; Kelber O; Enck P; Grundy D; Kreis ME
    Phytomedicine; 2006; 13 Suppl 5():100-6. PubMed ID: 16713220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.